Correction: Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients.

Where this comes from

• Record sourced from PubMed, PMID 42623378.
• Also identified by DOI 10.1371/journal.pone.0356789.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.